Riga, Latvia

Maris Veveris



 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maris Veveris: A Trailblazer in Innovation

Introduction: Maris Veveris, a visionary inventor hailing from Riga, LV, stands as a shining example of relentless passion for innovation and dedication to creating transformative technologies. With one patent to his name, his groundbreaking work has left an indelible mark on the world of inventions.

Latest Patents: Maris Veveris's notable patent is on Acetylsalicylic acid salts, which includes novel betaine salts such as 4-trimethylammoniobutanoate acetylsalicylic acid addition salt, L-carnitine acetylsalicylic acid addition salt, and meldonium acetylsalicylic acid addition salt. His innovation extends to the use of meldonium acetylsalicylate as an antiplatelet agent for treating various pathologies induced by platelet aggregation, as an anti-inflammatory, and antihyperlipidemic agent.

Career Highlights: Maris Veveris is a valuable asset to Tetra, Sia, a company at the forefront of innovation. His work ethic and determination have propelled him to create groundbreaking solutions that have garnered global recognition. His relentless pursuit of excellence has set him apart as a pioneer in his field.

Collaborations: Collaborating with esteemed colleagues such as Ivars Kalvins and Anatolijs Birmans has enriched Maris Veveris's creative process. Together, they have pushed the boundaries of innovation, fostering a culture of collaboration and mutual growth.

Conclusion: In conclusion, Maris Veveris's innovative spirit and unwavering commitment to excellence continue to inspire inventors and innovators worldwide. His contributions to the field of inventions have paved the way for transformative technologies that have the potential to shape the future. As a man of remarkable ingenuity, Maris Veveris is a true trailblazer in innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…